{"id":"standard-dose-of-unfractionated-heparin","safety":{"commonSideEffects":[{"rate":"1-10%","effect":"Bleeding (major and minor)"},{"rate":"0.5-3%","effect":"Heparin-induced thrombocytopenia (HIT)"},{"rate":"null","effect":"Thrombosis (paradoxical, in HIT)"},{"rate":"null","effect":"Osteoporosis (with prolonged use)"},{"rate":"null","effect":"Hyperkalemia"},{"rate":"null","effect":"Injection site reactions"}]},"_chembl":{"chemblId":"CHEMBL1159488","moleculeType":"Small molecule","molecularWeight":"711.47"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Unfractionated heparin (UFH) is a naturally occurring glycosaminoglycan that binds to antithrombin III and dramatically increases its ability to inhibit thrombin (Factor IIa) and Factor Xa. This prevents the formation of fibrin clots and the extension of existing thrombi. UFH has a rapid onset of action and is reversible, making it suitable for acute anticoagulation in hospital settings.","oneSentence":"Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:11.632Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute venous thromboembolism (deep vein thrombosis and pulmonary embolism) treatment and prevention"},{"name":"Acute coronary syndrome and myocardial infarction"},{"name":"Atrial fibrillation for stroke prevention"},{"name":"Prevention of thrombosis during cardiac surgery and percutaneous coronary intervention"},{"name":"Disseminated intravascular coagulation"}]},"trialDetails":[{"nctId":"NCT07494877","phase":"","title":"Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility","status":"RECRUITING","sponsor":"Tang-Du Hospital","startDate":"2025-09-01","conditions":"Infertility","enrollment":300},{"nctId":"NCT07497165","phase":"","title":"Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-11-01","conditions":"Relapsed/Refractory Multiple Myeloma (RRMM), Multiple Myeloma","enrollment":48},{"nctId":"NCT07492901","phase":"NA","title":"Impact of Ligament of Marshall Resection on Atrial Fibrillation Occurrence in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-11","conditions":"Post Operative Arrythmia","enrollment":220},{"nctId":"NCT07477977","phase":"NA","title":"Dose for Reversal of Heparin After Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03-01","conditions":"Open Heart Surgery","enrollment":195},{"nctId":"NCT07467889","phase":"","title":"Impact of CRRT on Serum Carnitine and Micronutrient Levels","status":"COMPLETED","sponsor":"Gulhane Training and Research Hospital","startDate":"2023-01-01","conditions":"Acute Kidney Injury (Nontraumatic), Critical Illness","enrollment":43},{"nctId":"NCT07464808","phase":"NA","title":"Utilizing Anti-Factor Xa as a Predictive Tool for Optimizing Outcome in Burn Patients' Management","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-11-28","conditions":"Venous Thromboembolic Event","enrollment":25},{"nctId":"NCT05540340","phase":"PHASE1","title":"A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-09-09","conditions":"Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell","enrollment":39},{"nctId":"NCT06549842","phase":"NA","title":"Safe and Fast Radial Hemostasis Using Synergistic Strategies: SAFE & FAST Trial","status":"COMPLETED","sponsor":"Regional Hospital of Scranton","startDate":"2024-08-15","conditions":"Cardiovascular Diseases, Bleeding, Arterial Puncture","enrollment":451},{"nctId":"NCT06679829","phase":"PHASE2","title":"A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2024-11-06","conditions":"Multiple Myeloma","enrollment":215},{"nctId":"NCT07404345","phase":"PHASE4","title":"Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)","status":"NOT_YET_RECRUITING","sponsor":"Hospital Civil de Guadalajara","startDate":"2026-03-01","conditions":"Hemodialysis Access Failure, Kidney Disease, End-Stage, Hemodialysis Catheter","enrollment":54},{"nctId":"NCT06094920","phase":"PHASE4","title":"Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2024-07-29","conditions":"Diabetes Mellitus Type 2 With Proteinuria, Diabetes Mellitus, Type 2, Diabetes Mellitus","enrollment":12},{"nctId":"NCT07201519","phase":"PHASE2","title":"Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy","status":"RECRUITING","sponsor":"Michael J Cavnar, MD","startDate":"2026-01-23","conditions":"Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma","enrollment":80},{"nctId":"NCT07388056","phase":"","title":"Efficacy and Safety of Extended Anticoagulant Therapy in Cancer Associated Thrombosis in Thai Population","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2012-01-01","conditions":"Cancer-associated Thrombosis","enrollment":169},{"nctId":"NCT07352800","phase":"PHASE2","title":"Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia","status":"RECRUITING","sponsor":"Aplagon Oy","startDate":"2026-01-29","conditions":"Peripheral Arterial Occlusive Disease, Chronic Limb-Threatening Ischemia","enrollment":42},{"nctId":"NCT07352358","phase":"PHASE4","title":"Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-30","conditions":"Cerebral Venous Thrombosis","enrollment":72},{"nctId":"NCT06195540","phase":"PHASE3","title":"RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing","status":"RECRUITING","sponsor":"University Hospital, Angers","startDate":"2024-07-19","conditions":"Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism","enrollment":1424},{"nctId":"NCT07183605","phase":"NA","title":"Comparison of Heparin Anti-Xa Activity From Central Venous Catheter Samples Using a 5 mL Syringe Flush or a Vacuum Tube Flush Versus Peripheral Vein Samples in ICU Patients","status":"RECRUITING","sponsor":"Centre Hospitalier Régional d'Orléans","startDate":"2025-09-22","conditions":"Anticoagulants and Bleeding Disorders","enrollment":30},{"nctId":"NCT06966765","phase":"PHASE3","title":"Accelerated vs Standard Approach to Continuous Veno-venous Hemodiafiltration Post-hemoperfusion (ASAP) in Severe Acute Diquat Poisoning","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2027-01-01","conditions":"Diquat Poisoning","enrollment":267},{"nctId":"NCT07228663","phase":"PHASE3","title":"Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-12-01","conditions":"Hip Fracture Surgery, Cardiovascular Prevention, Venous Thromboembolism (VTE)","enrollment":100},{"nctId":"NCT06004674","phase":"PHASE2","title":"Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2023-12-26","conditions":"Adverse Pregnancy Outcome","enrollment":20},{"nctId":"NCT05990894","phase":"","title":"Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","startDate":"2020-07-01","conditions":"Cerebral Venous Thrombosis","enrollment":170},{"nctId":"NCT04635241","phase":"PHASE2, PHASE3","title":"Inhaled Heparin for Hospitalised COVID-19 Patients","status":"COMPLETED","sponsor":"Australian National University","startDate":"2020-06-01","conditions":"Covid19","enrollment":485},{"nctId":"NCT07005661","phase":"PHASE2, PHASE3","title":"Use of PRP in Open Surgery for Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-06-30","conditions":"Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP)","enrollment":250},{"nctId":"NCT05735639","phase":"PHASE4","title":"THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-01-22","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":6660},{"nctId":"NCT02798471","phase":"PHASE3","title":"Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2017-03-27","conditions":"Venous Thromboembolism (VTE), Pulmonary Embolism, Deep Vein Thrombosis (DVT)","enrollment":290},{"nctId":"NCT06833827","phase":"NA","title":"'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-02","conditions":"Pulmonary Embolism Acute","enrollment":111},{"nctId":"NCT05245877","phase":"PHASE4","title":"Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery","status":"RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2022-08-17","conditions":"Pancreas Cancer, Pancreas Neoplasm, Surgery","enrollment":800},{"nctId":"NCT04362085","phase":"PHASE3","title":"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2020-05-11","conditions":"COVID-19","enrollment":465},{"nctId":"NCT04507178","phase":"PHASE2","title":"Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-02-02","conditions":"Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia","enrollment":100},{"nctId":"NCT04710732","phase":"PHASE4","title":"Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test.","status":"TERMINATED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2021-03-01","conditions":"Venous Thromboembolism","enrollment":9},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT03152058","phase":"PHASE2","title":"IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy","status":"RECRUITING","sponsor":"David Ware Branch","startDate":"2017-05-17","conditions":"High Risk Pregnancy, Pregnancy Complications, Antiphospholipid Syndrome in Pregnancy","enrollment":55},{"nctId":"NCT04427098","phase":"PHASE2","title":"Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2020-05-22","conditions":"COVID-19","enrollment":301},{"nctId":"NCT02464969","phase":"PHASE4","title":"Apixaban for the Acute Treatment of Venous Thromboembolism in Children","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2015-11-22","conditions":"Venous Thromboembolism","enrollment":229},{"nctId":"NCT06662253","phase":"PHASE2, PHASE3","title":"Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"Alexandre Tran","startDate":"2025-01","conditions":"Venous Thromboembolism (VTE), Trauma Related Injuries","enrollment":150},{"nctId":"NCT04436991","phase":"","title":"Antibiotic Dosing in Geriatric Patients At the Emergency Department","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2018-01-03","conditions":"Elderly Infection, Frailty, Frail Elderly Syndrome","enrollment":180},{"nctId":"NCT06583889","phase":"NA","title":"Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-08-09","conditions":"Cerebral Venous Sinus Thrombosis","enrollment":224},{"nctId":"NCT03638817","phase":"PHASE2","title":"Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2019-08-02","conditions":"Thrombocytopenia","enrollment":13},{"nctId":"NCT05426031","phase":"PHASE4","title":"Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"University of Miami","startDate":"2022-06-28","conditions":"Coagulation; Intravascular","enrollment":130},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06487052","phase":"NA","title":"Evaluation of the Standard Catheter-directed Thrombolysis Effectiveness in Intermediate-High-Risk Pulmonary Embolism Patients","status":"RECRUITING","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2024-01-10","conditions":"Pulmonary Embolism Acute","enrollment":100},{"nctId":"NCT00089895","phase":"PHASE3","title":"EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-11-01","conditions":"Myocardial Ischemia, Acute Coronary Syndrome","enrollment":9406},{"nctId":"NCT04483960","phase":"PHASE3","title":"Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Melbourne","startDate":"2020-07-28","conditions":"SARS-CoV-2 Infection (COVID-19)","enrollment":2200},{"nctId":"NCT03517098","phase":"NA","title":"Enhanced Recovery After Surgery (ERAS) Pathway for Primary Hip and Knee Arthroplasty","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2021-02-01","conditions":"Arthroplasty, Replacement, Hip, Knee","enrollment":640},{"nctId":"NCT06153394","phase":"PHASE3","title":"Prolonged Hypercoagulability Following Major Liver Resection for Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Western University, Canada","startDate":"2024-06-01","conditions":"Hepatic Disease, Surgery-Complications, Hypercoagulability","enrollment":50},{"nctId":"NCT05540834","phase":"PHASE2","title":"Viscoelastic Testing Guided Tissue Plasminogen Activator Treatment in Acute Respiratory Failure","status":"RECRUITING","sponsor":"South West Sydney Local Health District","startDate":"2022-05-18","conditions":"Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown","enrollment":70},{"nctId":"NCT04571645","phase":"PHASE3","title":"Dociparstat in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"Jazz Pharmaceuticals","startDate":"2021-04-30","conditions":"Acute Myeloid Leukemia","enrollment":9},{"nctId":"NCT02342444","phase":"PHASE4","title":"Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2014-02","conditions":"Trauma, Surgery, Deep Vein Thrombosis (DVT)","enrollment":606},{"nctId":"NCT05184101","phase":"PHASE2, PHASE3","title":"Inhaled Heparin for Hospitalised Patients With Coronavirus Disease 2019 (COVID-19)","status":"WITHDRAWN","sponsor":"Australian National University","startDate":"2023-08","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04561648","phase":"NA","title":"Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.","status":"UNKNOWN","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2020-08-01","conditions":"Radial Artery Occlusion","enrollment":1988},{"nctId":"NCT02604238","phase":"PHASE3","title":"Efficacy and Safety of Half Dose Alteplase Added to Heparine, in Patients With Moderate Pulmonary Embolism","status":"WITHDRAWN","sponsor":"Azienda U.S.L. 1 di Massa e Carrara","startDate":"2016-03","conditions":"Pulmonary Embolism","enrollment":""},{"nctId":"NCT04409834","phase":"PHASE4","title":"Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial","status":"COMPLETED","sponsor":"The TIMI Study Group","startDate":"2020-08-05","conditions":"COVID-19, Venous Thromboembolism, Arterial Thrombosis","enrollment":390},{"nctId":"NCT04536363","phase":"PHASE2","title":"Cri Analog PG1 Effectiveness and Safety in Covid-19","status":"WITHDRAWN","sponsor":"Alonso Vera Torres","startDate":"2020-12-03","conditions":"Covid19","enrollment":""},{"nctId":"NCT02873338","phase":"PHASE2","title":"Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2016-08","conditions":"Acute Myeloid Leukemia","enrollment":75},{"nctId":"NCT06025162","phase":"","title":"Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma","status":"UNKNOWN","sponsor":"Methodist Health System","startDate":"2023-07-21","conditions":"Thromboembolism, Venous","enrollment":100},{"nctId":"NCT04725201","phase":"PHASE4","title":"Prospective Study on the Role of Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization","status":"UNKNOWN","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-05-24","conditions":"Amputation; Traumatic, Hand","enrollment":188},{"nctId":"NCT04646655","phase":"PHASE3","title":"Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19","status":"COMPLETED","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2020-07-27","conditions":"Covid19, Thrombosis","enrollment":142},{"nctId":"NCT04305106","phase":"PHASE3","title":"Bevacizumab in Patients With Severe Covid-19","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-01-12","conditions":"COVID-19 Pneumonia","enrollment":588},{"nctId":"NCT03516656","phase":"EARLY_PHASE1","title":"Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin","status":"COMPLETED","sponsor":"University of Utah","startDate":"2018-03-23","conditions":"Deep Vein Thrombosis, Pulmonary Embolism, Venous Thromboembolism","enrollment":20},{"nctId":"NCT04635839","phase":"PHASE4","title":"Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-12-15","conditions":"Pregnancy Related, Antepartum DVT","enrollment":46},{"nctId":"NCT02923115","phase":"PHASE1, PHASE2","title":"Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2016-06-23","conditions":"Pulmonary Embolism, Thrombotic Disease","enrollment":134},{"nctId":"NCT04655586","phase":"PHASE2, PHASE3","title":"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19","status":"COMPLETED","sponsor":"ARCA Biopharma, Inc.","startDate":"2020-12-10","conditions":"Covid19","enrollment":160},{"nctId":"NCT04569279","phase":"PHASE3","title":"Rivaroxaban vs. Warfarin in CVT Treatment","status":"COMPLETED","sponsor":"Damascus University","startDate":"2017-09-01","conditions":"Cerebral Vein Thrombosis","enrollment":71},{"nctId":"NCT01077895","phase":"PHASE3","title":"The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function","status":"WITHDRAWN","sponsor":"University Hospital, Ghent","startDate":"2010-02","conditions":"Critically Ill, Intra-Abdominal Hypertension, Abdominal Compartment Syndrome","enrollment":""},{"nctId":"NCT03568838","phase":"PHASE4","title":"Prolonged Enoxaparin in Primary Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2018-06-28","conditions":"Myocardial Infarction","enrollment":100},{"nctId":"NCT05493163","phase":"PHASE4","title":"Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism","status":"RECRUITING","sponsor":"Faculty Hospital Kralovske Vinohrady","startDate":"2022-10-19","conditions":"Pulmonary Embolism","enrollment":558},{"nctId":"NCT05591872","phase":"PHASE3","title":"Low Dose Heparin Factorial Trial","status":"UNKNOWN","sponsor":"Tabba Heart Institute","startDate":"2022-05-09","conditions":"Radial Artery Occlusion","enrollment":800},{"nctId":"NCT03145675","phase":"PHASE4","title":"Optimizing the Anticoagulation Regimen of Enoxaparin During Percutaneous Coronary Intervention (OPTIENOX-PCI)","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2017-05-12","conditions":"Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":378},{"nctId":"NCT04730856","phase":"NA","title":"Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)","status":"COMPLETED","sponsor":"Hospital Universitario Infanta Leonor","startDate":"2021-02-01","conditions":"Covid19, Thrombosis","enrollment":311},{"nctId":"NCT01442792","phase":"PHASE2","title":"Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-10-12","conditions":"Cardiovascular Disease, Coronary Artery Disease","enrollment":108},{"nctId":"NCT02557672","phase":"PHASE4","title":"PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-08","conditions":"Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures","enrollment":106},{"nctId":"NCT04977960","phase":"PHASE2","title":"Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2022-09","conditions":"COVID-19 Acute Respiratory Distress Syndrome","enrollment":180},{"nctId":"NCT01999179","phase":"NA","title":"Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2014-06","conditions":"Venous Thrombosis, Neoplasms","enrollment":27},{"nctId":"NCT03309137","phase":"NA","title":"Device for Bacteremia Prevention in Post Cardiac Surgical Intensive Care Unit Patients","status":"COMPLETED","sponsor":"Alison Fox-Robichaud","startDate":"2017-11-19","conditions":"Infection, Heart; Surgery, Heart, Functional Disturbance as Result, Bacteremia","enrollment":100},{"nctId":"NCT04492254","phase":"PHASE3","title":"Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients","status":"TERMINATED","sponsor":"Thrombosis Research Institute","startDate":"2020-10-27","conditions":"COVID-19","enrollment":219},{"nctId":"NCT05255848","phase":"PHASE2, PHASE3","title":"Nebulised Heparin in Patients With COVID-19 Pneumonia","status":"UNKNOWN","sponsor":"Lady Reading Hospital, Pakistan","startDate":"2022-06-20","conditions":"COVID-19 Pneumonia","enrollment":180},{"nctId":"NCT00493896","phase":"PHASE3","title":"Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients","status":"TERMINATED","sponsor":"Eastern Virginia Medical School","startDate":"2007-07","conditions":"Venous Thromboembolism","enrollment":27},{"nctId":"NCT05302947","phase":"","title":"COVID-19 Study at the Russian Clinical and Research Center of Gerontology of the Pirogov RNRMU","status":"COMPLETED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2020-02-01","conditions":"COVID-19, Mild to Moderate","enrollment":154},{"nctId":"NCT04394182","phase":"NA","title":"Ultra Low Doses of Therapy With Radiation Applicated to COVID-19","status":"SUSPENDED","sponsor":"Fundacion GenesisCare","startDate":"2020-04-21","conditions":"Pneumonia, Viral, Cytokine Storm","enrollment":15},{"nctId":"NCT05279391","phase":"NA","title":"Combination of Inhaled DNase, Baricitinib and Tocilizumab in Severe COVID-19","status":"UNKNOWN","sponsor":"Democritus University of Thrace","startDate":"2020-10-25","conditions":"COVID-19 Severe Respiratory Failure","enrollment":150},{"nctId":"NCT02501434","phase":"PHASE2","title":"Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin","status":"SUSPENDED","sponsor":"Robert F. James","startDate":"2016-04","conditions":"Aneurysmal Subarachnoid Hemorrhage, Neurobehavioral Manifestations, Vasospasm, Intracranial","enrollment":88},{"nctId":"NCT04377997","phase":"PHASE2","title":"Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2020-05-15","conditions":"Cardiovascular Diseases, COVID-19","enrollment":300},{"nctId":"NCT05237843","phase":"PHASE1","title":"Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-03-01","conditions":"Recurrent Pregnancy Loss","enrollment":70},{"nctId":"NCT04357730","phase":"PHASE2","title":"Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2020-05-14","conditions":"Severe Acute Respiratory Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome","enrollment":50},{"nctId":"NCT00457951","phase":"PHASE2","title":"A Study Designed to Evaluate ODSH in Subjects With Exacerbations of COPD","status":"TERMINATED","sponsor":"Jazz Pharmaceuticals","startDate":"2007-04","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":158},{"nctId":"NCT04401293","phase":"PHASE3","title":"Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2020-04-26","conditions":"Sars-CoV2, COVID","enrollment":257},{"nctId":"NCT04558125","phase":"PHASE4","title":"Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2020-09-08","conditions":"Pulmonary Embolism, COVID","enrollment":2},{"nctId":"NCT04444700","phase":"PHASE3","title":"A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2020-07-04","conditions":"COVID, Coronavirus Infection, Severe Acute Respiratory Syndrome","enrollment":465},{"nctId":"NCT02412982","phase":"PHASE4","title":"Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2016-03","conditions":"Traumatic Injury, Venous Thromboembolism","enrollment":103},{"nctId":"NCT02486666","phase":"PHASE3","title":"Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH Dose","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2016-03","conditions":"Venous Thromboembolism","enrollment":20},{"nctId":"NCT04297839","phase":"PHASE3","title":"Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis","status":"SUSPENDED","sponsor":"University of Sao Paulo General Hospital","startDate":"2019-02-12","conditions":"Hemodialysis Complication, Acute Kidney Injury, Anticoagulant Toxicity","enrollment":200},{"nctId":"NCT04345848","phase":"PHASE3","title":"Preventing COVID-19 Complications With Low- and High-dose Anticoagulation","status":"TERMINATED","sponsor":"University Hospital, Geneva","startDate":"2020-04-28","conditions":"COVID, Sars-CoV2","enrollment":160},{"nctId":"NCT04486508","phase":"PHASE3","title":"Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19","status":"COMPLETED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2020-07-30","conditions":"Covid19","enrollment":600},{"nctId":"NCT04984135","phase":"","title":"DCB Angioplasty for Coronary Lesions: an OCT Analysis","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Dalian Medical University","startDate":"2020-12-01","conditions":"Coronary Stenosis, Drug-coated Balloon","enrollment":70},{"nctId":"NCT04485429","phase":"PHASE3","title":"Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia","status":"WITHDRAWN","sponsor":"D'Or Institute for Research and Education","startDate":"2020-07-20","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04158973","phase":"NA","title":"CHIPs-VTE Study in Hospitalized Patients With Lung Cancer","status":"UNKNOWN","sponsor":"China-Japan Friendship Hospital","startDate":"2021-12-01","conditions":"Venous Thromboembolic Disease, Pulmonary Embolism, Deep Venous Thrombosis","enrollment":3200},{"nctId":"NCT01608906","phase":"NA","title":"Using Intravenous Heparin Versus Standard of Care Subcutaneous Heparin to Prevent Clots After Surgery","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2007-05","conditions":"Venous Thrombosis","enrollment":152},{"nctId":"NCT01166997","phase":"PHASE3","title":"ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2010-07","conditions":"Submassive Pulmonary Embolism","enrollment":59}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":423,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard Dose of Unfractionated Heparin","genericName":"Standard Dose of Unfractionated Heparin","companyName":"University of California, Los Angeles","companyId":"university-of-california-los-angeles","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors. Used for Acute venous thromboembolism (deep vein thrombosis and pulmonary embolism) treatment and prevention, Acute coronary syndrome and myocardial infarction, Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}